LeMaitre Vascular director proposes $434K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LeMaitre Vascular, Inc. (LMAT) reports that director Lawrence J. Jasinski filed a notice of a proposed sale of 3,943 common shares, with an aggregate market value of $433,730 and an approximate sale date of May 7, 2026. The notice names Morgan Stanley Smith Barney LLC as the broker. The acquisition table lists 2,858 shares from a stock option exercise dated May 7, 2026, as well as performance-share and restricted-stock acquisitions.
Key Figures
Key Terms
Stock Option Exercise financial
Restricted Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.